Strategy for identifying an efficient dosage of beta-blocker for elderly patients with myocardial ischemia and preserved left ventricular function;Estratégia para individualizar uma dose eficiente de betabloqueador em pacientes idosos com isquemia miocárdica e função ventricular esquerda preservada

Arquivos Brasileiros de Cardiologia

Volumn 82, Issue 6, 2004, Pages 551-558

  Serro Azul, Joao Batista ^a,b   Wajngarten, Mauricio ^a,b   Nussbacher, Amit ^a,b   Giorgi, Maria C ^a,b   Meneghetti, José C ^a,b   De Oliveira, Marco A ^a,b   Abe, Rubens ^a,b   Dal Bó, Creusa ^a,b   Pierri, Humberto ^a,b   Gebara, Otávio ^a,b  

^a FMUSP ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Beta blocker; Elderly; Myocardial ischemia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

AGED; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DAILY LIFE ACTIVITY; DRUG DOSE REGIMEN; DRUG SAFETY; EXERCISE TEST; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART SCINTISCANNING; HEART VENTRICLE FUNCTION; HEART VENTRICLE PERFORMANCE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL DOCUMENTATION; ST SEGMENT;

EID: 3242674455     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yusuf S, Peto R, Lewis J, et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-71.
2. Vantrimpont P, Rouleau JL, Wun CC et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement(SAVE) Study. SAVE Investigators. J Am Coll Cardiol 1997; 29: 229-36.
3. Gottlieb SS, McCarter RJ, Vogel RA. Effect of β-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-97.
4. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997; 277: 115-21.
5. Fleg JL, Schulman S, O'Connor F, et al. Effects of acute β-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 1994; 90: 2333-41.
6. Fleg JL, Schulman SP, Gerstenblith G, et al. Additive effects of age and silent myocardial ischemia on the left ventricular response to upright cycle exercise. J Appl Physiol 1993; 75: 499-504.
7. Wilcox RG, Roland JM, Banks DC, et al. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. BMJ 1980; 280: 885-8.
8. Hjalmarson A, Herlitz J, Holmberg S, et al. The goteborg metoprolol trial: effects on mortality, and morbidity in acute myocardial infarction. Circulation 1983; 67(suppl 1): 1-26-1-32.
9. Norwegian Multicenter Study Group. Timolol-induced reductionin mortalityand reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-7.
10. Beta-blocker heart attack trial research group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982; 247: 1707-14.
11. Rochon PA, Tu JV, Anderson GM et al. Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet 2000; 356: 639-44.
12. Links JM, Becker LC, Shindledecker G, etal. Measurement of absolute leftventricular volume from gated blood pool studies. Circulation 1982; 65: 82-91.
13. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203-13.
14. Wajngarten M, Grupi C, Bellotti GM, et al. Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals. J Electrocardiol 1990; 23: 171-6.